SPRC Rasio cepet SciSparc Ltd

SciSparc Ltd promotes innovative CNS therapies through alliances with scientists, increasing the startup's prospects for acquisition. The brand's high authority within the medical community ensures stable investor confidence. This price chart demonstrates a metric at the level of 0.85. Meanwhile, business success relies on drug trial results, remaining independent of market cycles and macroeconomic shocks.

The quick ratio determines a company's ability to instantaneously settle short-term liabilities without liquidating inventory. The trend in strict solvency levels demonstrates the business's actual financial cushion. The calculation is based exclusively on cash and accounts receivable, excluding illiquid assets. For SciSparc Ltd (SPRC), which has no revenue, this indicator is critically important as it reflects the remaining investment capital available to fund clinical trials.